Copy to clipboard 
The German healthcare specialist SHS Capital, together with ING Corporate Investments and other co-investors, is investing in CAM Bioceramics.
CAM Bioceramics is focused on developing orthobiological calcium phosphate materials with application in orthobiologic hydroxyapatite coating powder for orthopedic, dental and spinal implants, bone graft substitutes, excipients, etc. As one of the leading companies in its field, CAM offers the unique combination of outstanding product and scientific know-how at the interface between chemistry, biology and material sciences combined with large scale production capacities to ensure constant supply and quality whilst remaining agile to provide continuous customer satisfaction.
The aim of the new partnership is to strengthen the base of the company further and to accelerate human resource and monetary investments to further customer satisfaction beyond where it is today. Amongst others, CAM can now benefit from the many years of experience as well as the extensive network of SHS in the Healthcare sector, which is expected to lead to additional collaboration and partnership opportunities with existing and new customers.
“We are delighted to have SHS and ING Corporate Investments on board, hence enabling CAM Bioceramics to serve our customers even better and to grow even faster. The existing Shareholders and the Management Team have consciously looked for the best partners to secure continuity and get access to additional and complementary business development opportunities. The partnership with SHS and ING is a validation of our strategy and capabilities and will fuel the company’s growth even further. The Management Team will remain fully intact and will continue to provide the best Customer Satisfaction possible to remain or to become your trusted partner for innovative calcium phosphate solutions and services worldwide,” explains CAM Shareholder and CEO Caspar J Hogeboom.
Source: CAM Bioceramics B.V.
